Cargando…
PB2349: A PHASE 1, OPEN-LABEL, MULTICENTER, DOSE-ESCALATION STUDY OF SGR-1505 AS MONOTHERAPY IN SUBJECTS WITH MATURE B-CELL MALIGNANCIES
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428951/ http://dx.doi.org/10.1097/01.HS9.0000976116.40906.a2 |
| _version_ | 1785090593948434432 |
|---|---|
| author | Olszewski, Adam Kahn, David Yoo, Brian Nie, Zhe Krilov, Goran Tan, Joanne Wright, Hamish Weiss, Daniel Yin, Wu Akinsanya, Karen |
| author_facet | Olszewski, Adam Kahn, David Yoo, Brian Nie, Zhe Krilov, Goran Tan, Joanne Wright, Hamish Weiss, Daniel Yin, Wu Akinsanya, Karen |
| author_sort | Olszewski, Adam |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428951 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104289512023-08-17 PB2349: A PHASE 1, OPEN-LABEL, MULTICENTER, DOSE-ESCALATION STUDY OF SGR-1505 AS MONOTHERAPY IN SUBJECTS WITH MATURE B-CELL MALIGNANCIES Olszewski, Adam Kahn, David Yoo, Brian Nie, Zhe Krilov, Goran Tan, Joanne Wright, Hamish Weiss, Daniel Yin, Wu Akinsanya, Karen Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428951/ http://dx.doi.org/10.1097/01.HS9.0000976116.40906.a2 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Olszewski, Adam Kahn, David Yoo, Brian Nie, Zhe Krilov, Goran Tan, Joanne Wright, Hamish Weiss, Daniel Yin, Wu Akinsanya, Karen PB2349: A PHASE 1, OPEN-LABEL, MULTICENTER, DOSE-ESCALATION STUDY OF SGR-1505 AS MONOTHERAPY IN SUBJECTS WITH MATURE B-CELL MALIGNANCIES |
| title | PB2349: A PHASE 1, OPEN-LABEL, MULTICENTER, DOSE-ESCALATION STUDY OF SGR-1505 AS MONOTHERAPY IN SUBJECTS WITH MATURE B-CELL MALIGNANCIES |
| title_full | PB2349: A PHASE 1, OPEN-LABEL, MULTICENTER, DOSE-ESCALATION STUDY OF SGR-1505 AS MONOTHERAPY IN SUBJECTS WITH MATURE B-CELL MALIGNANCIES |
| title_fullStr | PB2349: A PHASE 1, OPEN-LABEL, MULTICENTER, DOSE-ESCALATION STUDY OF SGR-1505 AS MONOTHERAPY IN SUBJECTS WITH MATURE B-CELL MALIGNANCIES |
| title_full_unstemmed | PB2349: A PHASE 1, OPEN-LABEL, MULTICENTER, DOSE-ESCALATION STUDY OF SGR-1505 AS MONOTHERAPY IN SUBJECTS WITH MATURE B-CELL MALIGNANCIES |
| title_short | PB2349: A PHASE 1, OPEN-LABEL, MULTICENTER, DOSE-ESCALATION STUDY OF SGR-1505 AS MONOTHERAPY IN SUBJECTS WITH MATURE B-CELL MALIGNANCIES |
| title_sort | pb2349: a phase 1, open-label, multicenter, dose-escalation study of sgr-1505 as monotherapy in subjects with mature b-cell malignancies |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428951/ http://dx.doi.org/10.1097/01.HS9.0000976116.40906.a2 |
| work_keys_str_mv | AT olszewskiadam pb2349aphase1openlabelmulticenterdoseescalationstudyofsgr1505asmonotherapyinsubjectswithmaturebcellmalignancies AT kahndavid pb2349aphase1openlabelmulticenterdoseescalationstudyofsgr1505asmonotherapyinsubjectswithmaturebcellmalignancies AT yoobrian pb2349aphase1openlabelmulticenterdoseescalationstudyofsgr1505asmonotherapyinsubjectswithmaturebcellmalignancies AT niezhe pb2349aphase1openlabelmulticenterdoseescalationstudyofsgr1505asmonotherapyinsubjectswithmaturebcellmalignancies AT krilovgoran pb2349aphase1openlabelmulticenterdoseescalationstudyofsgr1505asmonotherapyinsubjectswithmaturebcellmalignancies AT tanjoanne pb2349aphase1openlabelmulticenterdoseescalationstudyofsgr1505asmonotherapyinsubjectswithmaturebcellmalignancies AT wrighthamish pb2349aphase1openlabelmulticenterdoseescalationstudyofsgr1505asmonotherapyinsubjectswithmaturebcellmalignancies AT weissdaniel pb2349aphase1openlabelmulticenterdoseescalationstudyofsgr1505asmonotherapyinsubjectswithmaturebcellmalignancies AT yinwu pb2349aphase1openlabelmulticenterdoseescalationstudyofsgr1505asmonotherapyinsubjectswithmaturebcellmalignancies AT akinsanyakaren pb2349aphase1openlabelmulticenterdoseescalationstudyofsgr1505asmonotherapyinsubjectswithmaturebcellmalignancies |